Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides (Q21145828)
Jump to navigation
Jump to search
scientific article
- Identification of Human S100A9 as a Novel Target for Treatment of Autoimmune Disease via Binding to Quinoline-3-Carboxamides
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides |
scientific article |
|
Statements
Identification of human S100A9 as a novel target for treatment of autoimmune disease via binding to quinoline-3-carboxamides (English)
0 references
1 reference
Per Björk
1 reference
Anders Björk
1 reference
Martin Stenström
1 reference
David Liberg
1 reference
Anders Olsson
1 reference
Johannes Roth
1 reference
Fredrik Ivars
1 reference
Tomas Leanderson
1 reference
28 April 2009
0 references
7
0 references
4
0 references
e97
0 references
28 April 2009
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference